That someone was probably me. Since this email, however, there was a company presentation where Paul was pretty insistent that the 1.5mg/kg twice weekly would produce the same results - so I reckon they are leaning strongly to that dosage. I can understand why the FDA wants to find the lowest effective dosage, and why the company wants to please the FDA by going with this. My preference would be the 2mg because we know full well that it works, but happy to leave to the experts. If 1.5mg/kg works just as well, then we get the added benefit of knocking 25% off procurement costs of the API from Bene for a course of treatment too.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Reports Phase 3 Clinical Trial Update
Ann: PAR Reports Phase 3 Clinical Trial Update, page-33
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 0.225 |
5 | 44676 | 0.220 |
7 | 82313 | 0.215 |
13 | 181424 | 0.210 |
8 | 128042 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 131244 | 5 |
0.245 | 56918 | 2 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |